-
Press Room
-
Press Releases
-
Dec 23, 2013
10:30 AM
VolitionRx Announces Engagement of MissionIR Investor Relations Services
-
Dec 02, 2013
6:30 AM
VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps
-
Nov 29, 2013
8:30 AM
VolitionRx to Present at the 6th Annual LD Micro Conference
-
Nov 14, 2013
6:30 AM
VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark
-
Nov 07, 2013
6:30 AM
First VolitionRx Study Data Presented at CNAPS, Baltimore
-
Sep 26, 2013
7:30 AM
VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits
-
Sep 03, 2013
7:30 AM
VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
-
Jul 22, 2013
7:30 AM
VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits
-
May 29, 2013
7:30 AM
VolitionRx Embarks on Colorectal Cancer Trial with Hvidovre Hospital, Denmark
-
May 01, 2013
7:30 AM
Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic
-
Apr 04, 2013
7:30 AM
VolitionRx Files Two Patent Applications
-
Mar 26, 2013
7:00 AM
VolitionRx Hires Head of US Operations, Jason Terrell MD
-
Jan 09, 2013
6:30 AM
VolitionRx Announces Collaboration with Wales Cancer Bank